000423 东阿阿胶
已收盘 12-20 15:00:00
资讯
新帖
简况
12月20日东阿阿胶涨5.56%,中欧医疗健康混合A基金重仓该股
证券之星 · 16:06
12月20日东阿阿胶涨5.56%,中欧医疗健康混合A基金重仓该股
东阿阿胶涨5.56%,中泰证券一个月前给出“买入”评级
证券之星 · 16:06
东阿阿胶涨5.56%,中泰证券一个月前给出“买入”评级
《股市简讯》中证中药指数涨逾1%,习近平在澳门称传承创新发展中医药是大事
路透中文 · 11:58
《股市简讯》中证中药指数涨逾1%,习近平在澳门称传承创新发展中医药是大事
华润医药(03320.HK)附属累计增持东阿阿胶1%股份
阿斯达克财经 · 12-19 09:38
华润医药(03320.HK)附属累计增持东阿阿胶1%股份
金十数据整理:每日港股市场要闻速递(12月19日 周四)
美港电讯 · 12-19 09:08
金十数据整理:每日港股市场要闻速递(12月19日 周四)
华润医药附属华润医药投资累计增持东阿阿胶1%股本
新浪港股 · 12-19 08:05
华润医药附属华润医药投资累计增持东阿阿胶1%股本
华润医药(03320)附属华润医药投资累计增持东阿阿胶1%股本
智通财经 · 12-18 22:41
华润医药(03320)附属华润医药投资累计增持东阿阿胶1%股本
12月18日东阿阿胶发布公告,其股东增持642.46万股
证券之星 · 12-18 20:01
12月18日东阿阿胶发布公告,其股东增持642.46万股
东阿阿胶(000423.SZ)控股股东之一致行动人华润医药投资累计增持公司1%股份
智通财经 · 12-18 19:11
东阿阿胶(000423.SZ)控股股东之一致行动人华润医药投资累计增持公司1%股份
东阿阿胶最新公告:控股股东之一致行动人增持公司股份达到1% 拟继续增持
证券之星 · 12-18 19:00
东阿阿胶最新公告:控股股东之一致行动人增持公司股份达到1% 拟继续增持
东阿阿胶:控股股东之一致行动人增持公司股份达1%
美港电讯 · 12-18 18:56
东阿阿胶:控股股东之一致行动人增持公司股份达1%
开源证券:给予东阿阿胶买入评级
证券之星 · 12-13
开源证券:给予东阿阿胶买入评级
东阿阿胶(000423)12月5日主力资金净买入493.82万元
证券之星 · 12-06
东阿阿胶(000423)12月5日主力资金净买入493.82万元
东阿阿胶(000423)11月8日股东户数5.37万户,较上期增加2.1%
证券之星 · 11-21
东阿阿胶(000423)11月8日股东户数5.37万户,较上期增加2.1%
老百姓大药房直营门店卷入东阿阿胶追溯码重复风波 今年前三季度盈利下降
中金在线 · 11-21
老百姓大药房直营门店卷入东阿阿胶追溯码重复风波 今年前三季度盈利下降
东阿阿胶新提交3件商标注册申请
证券之星 · 11-21
东阿阿胶新提交3件商标注册申请
东阿阿胶获得发明专利授权:“猪苓汤、猪苓浸膏、猪苓固体制剂的制备方法”
证券之星 · 11-20
东阿阿胶获得发明专利授权:“猪苓汤、猪苓浸膏、猪苓固体制剂的制备方法”
东阿阿胶(000423)11月11日主力资金净卖出853.37万元
证券之星 · 11-12
东阿阿胶(000423)11月11日主力资金净卖出853.37万元
新董事长上任12天,东阿阿胶就陷入“追溯码风波”
市场资讯 · 11-09
新董事长上任12天,东阿阿胶就陷入“追溯码风波”
东阿阿胶与九州通及国大药房签订战略合作协议
市场资讯 · 11-07
东阿阿胶与九州通及国大药房签订战略合作协议
加载更多
公司概况
公司名称:
东阿阿胶股份有限公司
所属行业:
医药制造业
上市日期:
1996-07-29
主营业务:
东阿阿胶股份有限公司主营业务为阿胶和阿胶系列及其他中成药等产品的研发、生产和销售。公司主要产品有阿胶、复方阿胶浆、阿胶糕、“真颜”品牌系列、阿胶粉。2023年东阿阿胶品牌强度和品牌价值得到了跳跃式提升,第14次入围世界品牌实验室发布的“中国500最具价值品牌”,荣获第十四届虎啸奖【联合营销类】金奖、“中国中药企业TOP100排行榜”、上榜中国最具品牌价值榜单(中华老字号),荣登健康产业品牌榜及健康产业品牌价值榜。6月19日,世界品牌实验室(World Brand Lab)发布了2024年《中国500最具价值品牌》分析报告,东阿阿胶第15次荣登《中国500最具价值品牌》榜单,以438.37亿元人民币的品牌价值位列榜单第249位。
发行价格:
5.28
{"stockData":{"symbol":"000423","market":"SZ","secType":"STK","nameCN":"东阿阿胶","latestPrice":63.2,"timestamp":1734678198000,"preClose":59.87,"halted":0,"volume":12642101,"delay":0,"floatShares":644000000,"shares":644000000,"eps":2.3591,"marketStatus":"已收盘","marketStatusCode":5,"change":3.33,"latestTime":"12-20 15:00:00","open":60,"high":63.95,"low":59.85,"amount":792000000,"amplitude":0.0685,"askPrice":63.21,"askSize":95,"bidPrice":63.2,"bidSize":19,"shortable":0,"etf":0,"ttmEps":2.3591,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":59.87,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":65.86,"lowLimit":53.88,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":643976824,"pbRate":3.89,"roa":"--","roe":"10.62%","epsLYR":1.79,"committee":0.076549,"marketValue":40699000000,"floatMarketCap":40699000000,"peRate":26.789876,"changeRate":0.0556,"turnoverRate":0.0196,"status":0},"requestUrl":"/m/hq/s/000423","defaultTab":"news","newsList":[{"id":"2492493262","title":"12月20日东阿阿胶涨5.56%,中欧医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492493262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492493262?lang=zh_cn&edition=full","pubTime":"2024-12-20 16:06","pubTimestamp":1734682013,"startTime":"0","endTime":"0","summary":"证券之星消息,12月20日东阿阿胶涨5.56%,收盘报63.2元,换手率1.96%,成交量12.64万手,成交额7.92亿元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共87家,其中持有数量最多的公募基金为中欧医疗健康混合A。中欧医疗健康混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000025095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","159760","BK0010","BK0188","BK0175","BK0028","BK0239","SG9999014674.SGD","000423","BK0183","BK0187"],"gpt_icon":0},{"id":"2492493034","title":"东阿阿胶涨5.56%,中泰证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2492493034","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492493034?lang=zh_cn&edition=full","pubTime":"2024-12-20 16:06","pubTimestamp":1734682008,"startTime":"0","endTime":"0","summary":"今日东阿阿胶(000423)涨5.56%,收盘报63.2元。2024年11月5日,中泰证券研究员祝嘉琦,孙宇瑶发布了对东阿阿胶的研报《Q3高质量增长,业绩可持续性强》,该研报对东阿阿胶给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为78.62%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为中金公司的朱言音。东阿阿胶(000423)个股概况:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000025093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000423","600918"],"gpt_icon":0},{"id":"2492452049","title":"《股市简讯》中证中药指数涨逾1%,习近平在澳门称传承创新发展中医药是大事","url":"https://stock-news.laohu8.com/highlight/detail?id=2492452049","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492452049?lang=zh_cn&edition=full","pubTime":"2024-12-20 11:58","pubTimestamp":1734667137,"startTime":"0","endTime":"0","summary":"《股市简讯》中证中药指数涨逾1%,习近平在澳门称传承创新发展中医药是大事* 中国股市中证中药指数.CSI930641周五早盘收升1.2%;国家主席习近平近日在澳门科技大学考察时称,传承创新发展中医药是件大事。* 新华社周四报导称,习近平在澳门科技大学考察时听取中药质量研究、月球与行星科学国家重点实验室情况介绍,了解最新科研成果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241220:nL4S3NL094:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0187","000423","BK0185","SG9999014674.SGD","600436","BK0175","BK0196","BK0239","BK0010","BK0028","BK0012","600422","BK0183","000999","BK0188"],"gpt_icon":0},{"id":"2492984011","title":"华润医药(03320.HK)附属累计增持东阿阿胶1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2492984011","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492984011?lang=zh_cn&edition=full","pubTime":"2024-12-19 09:38","pubTimestamp":1734572280,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 宣布,全资附属华润医药投资于今年11月8日至12月18日期间,透过深圳证券交易所交易系统的集中竞价交易,累计增持东阿阿胶股份共约642.46股,占共总股本约1%。于增持后,目前东阿阿胶由华润医药投资持股约10.02%,并由华润医药旗下非全资附属华润东阿阿胶持股约23.56%,换言之华润医药实际控股东阿阿胶约33.58%股权。(gc/w)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-18 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240827115742257_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240827115742257_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1405147/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["000423","03320","BK1570","BK1191","BK0188","BK0010","SG9999014674.SGD","BK0183","BK0187","BK0196","BK0239","BK0175","BK0028"],"gpt_icon":0},{"id":"2492167947","title":"金十数据整理:每日港股市场要闻速递(12月19日 周四)","url":"https://stock-news.laohu8.com/highlight/detail?id=2492167947","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492167947?lang=zh_cn&edition=full","pubTime":"2024-12-19 09:08","pubTimestamp":1734570483,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["US30Y.BOND","BK0196","GLP","399300","IVV","OEF","000423","00639","06963","US5Y.BOND","LU2023250504.SGD","OEX","US3Y.BOND","IE00B1BXHZ80.USD","LU0234572021.USD","LU1989772840.SGD","UPRO","US10Y.BOND","US12M.BOND","601963","HSTECH",".SPX","SH","US7Y.BOND","ESmain","HK0000934320.USD","01963","01798","US2Y.BOND","03692","00012","06066","00697","159982","01478","07226","SPXU","US6M.BOND","YANG","03320","SDS","LU1116320901.HKD","MRK","01501","03377","SG9999001176.USD","159891","SPY","HSCEI","SSO"],"gpt_icon":0},{"id":"2492516192","title":"华润医药附属华润医药投资累计增持东阿阿胶1%股本","url":"https://stock-news.laohu8.com/highlight/detail?id=2492516192","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492516192?lang=zh_cn&edition=full","pubTime":"2024-12-19 08:05","pubTimestamp":1734566700,"startTime":"0","endTime":"0","summary":" 华润医药公布,于2024年11月8日至2024年12月18日期间,该公司全资附属公司华润医药投资透过深圳证券交易所交易系统的集中竞价交易累计收购东阿阿胶额外约642.46万股份。 截至本公告日期及于上述增持股份后,东阿阿胶由华润医药投资持有约10.02%股权及由该公司透过其非全资附属公司华润东阿阿胶有限公司持有约23.56%股权,且该集团实际控股东阿阿胶约33.58%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-19/doc-inczxzyc7064203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0175","BK1191","BK0183","03320","SG9999014674.SGD","000423","BK0239","BK0187","BK0196","BK0188","BK1570","BK0010"],"gpt_icon":0},{"id":"2492818120","title":"华润医药(03320)附属华润医药投资累计增持东阿阿胶1%股本","url":"https://stock-news.laohu8.com/highlight/detail?id=2492818120","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492818120?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:41","pubTimestamp":1734532899,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)公布,于2024年11月8日至2024年12月18日期间,该公司全资附属公司华润医药投资透过深圳证券交易所交易系统的集中竞价交易累计收购东阿阿胶额外约642.46万股份(占东阿阿胶总股本的1.00%,不包括于指定账户持有的东阿阿胶的回购股份)。截至本公告日期及于上述增持股份后,东阿阿胶由华润医药投资持有约10.02%股权及由该公司透过其非全资附属公司华润东阿阿胶有限公司持有约23.56%股权,且该集团实际控股东阿阿胶约33.58%。东阿阿胶作为该公司附属公司入账。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000423","BK0010","BK0028","BK0175","BK0183","BK0188","BK1570","BK0196","SG9999014674.SGD","03320","BK1191","BK0239","BK0187"],"gpt_icon":0},{"id":"2492849907","title":"12月18日东阿阿胶发布公告,其股东增持642.46万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492849907","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492849907?lang=zh_cn&edition=full","pubTime":"2024-12-18 20:01","pubTimestamp":1734523277,"startTime":"0","endTime":"0","summary":"证券之星消息,12月18日东阿阿胶发布公告《东阿阿胶:关于控股股东之一致行动人增持公司股份达到1%暨后续增持计划的公告》,其股东华润医药投资有限公司于2024年11月8日至2024年12月18日间合计增持642.46万股,占公司目前总股本的0.9976%,变动期间该股股价下跌0.24%,截止12月18日收盘报59.4元。股东增减持详情见下表:根据东阿阿胶2024年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800035385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0010","BK0239","BK0188","BK0183","BK0196","BK0175","BK0187","BK0028","000423","SG9999014674.SGD"],"gpt_icon":0},{"id":"2492065909","title":"东阿阿胶(000423.SZ)控股股东之一致行动人华润医药投资累计增持公司1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2492065909","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492065909?lang=zh_cn&edition=full","pubTime":"2024-12-18 19:11","pubTimestamp":1734520302,"startTime":"0","endTime":"0","summary":"华润医药投资拟自2024年11月8日起6个月内通过深圳证券交易所允许的方式继续增持公司股份,总增持股份数量不低于总股本的1%,且不超过总股本的1.2%。截至2024年12月18日,华润医药投资已累计增持公司股份642.46万股,占公司总股本的比例为1%,后续拟增持不超过总股本的0.2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226669.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1570","BK0028","BK0187","BK0188","03320","000423","BK1191","SG9999014674.SGD","BK0239","BK0175","BK0196","BK0010","BK0183"],"gpt_icon":0},{"id":"2492909776","title":"东阿阿胶最新公告:控股股东之一致行动人增持公司股份达到1% 拟继续增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2492909776","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492909776?lang=zh_cn&edition=full","pubTime":"2024-12-18 19:00","pubTimestamp":1734519653,"startTime":"0","endTime":"0","summary":"东阿阿胶公告,公司控股股东华润东阿阿胶之一致行动人华润医药投资,于2024年11月8日至2024年12月18日通过深圳证券交易所交易系统以集中竞价交易方式累计增持公司股份642.46万股,占公司总股本的比例为1.00%。华润医药投资拟自2024年11月8日起6个月内继续增持公司股份,总增持股份数量(含本次已增持)不低于总股本的1%(即642.46万股),且不超过总股本的1.2%(即770.96万股)。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800032971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000423","BK0187","BK0196","BK0239","BK0010","BK0028","BK0188","SG9999014674.SGD","BK0175","BK0183"],"gpt_icon":0},{"id":"2492067509","title":"东阿阿胶:控股股东之一致行动人增持公司股份达1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492067509","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492067509?lang=zh_cn&edition=full","pubTime":"2024-12-18 18:56","pubTimestamp":1734519396,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["000423","03320","BK1570","BK1191","BK0188","BK0010","SG9999014674.SGD","BK0183","BK0187","BK0196","BK0239","BK0175","BK0028"],"gpt_icon":0},{"id":"2491346519","title":"开源证券:给予东阿阿胶买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2491346519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491346519?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:51","pubTimestamp":1734079894,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,巢舒然近期对东阿阿胶进行研究并发布了研究报告《公司首次覆盖报告:“药品+健康消费品”双轮驱动,滋补品牌焕新生》,本报告对东阿阿胶给出买入评级,当前股价为59.95元。公司主要从事阿胶及系列中成药、保健食品的研发、生产和销售,主要产品有阿胶系列及“皇家围场1619”。最新盈利预测明细如下:该股最近90天内共有11家机构给出评级,买入评级8家,增持评级3家;过去90天内机构目标均价为74.99。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300029102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","000423"],"gpt_icon":0},{"id":"2489442427","title":"东阿阿胶(000423)12月5日主力资金净买入493.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489442427","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489442427?lang=zh_cn&edition=full","pubTime":"2024-12-06 09:20","pubTimestamp":1733448050,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年12月5日收盘,东阿阿胶报收于57.44元,下跌1.69%,换手率0.66%,成交量4.27万手,成交额2.45亿元。近5日资金流向一览见下表:东阿阿胶融资融券信息显示,融资方面,当日融资买入2438.71万元,融资偿还1041.59万元,融资净买入1397.13万元。东阿阿胶主营业务:主要从事阿胶和阿胶系列及其他中成药等产品的研发、生产和销售,是阿胶行业标准制定的引领者,是中式滋补健康引领者和中药企业高质量发展的典范。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600008897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000423","BK0183","BK0188","BK0196","BK0239","BK0175","BK0028","SG9999014674.SGD","BK0187","BK0010"],"gpt_icon":0},{"id":"2485454565","title":"东阿阿胶(000423)11月8日股东户数5.37万户,较上期增加2.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485454565","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485454565?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:01","pubTimestamp":1732179701,"startTime":"0","endTime":"0","summary":"证券之星消息,近日东阿阿胶披露,截至2024年11月8日公司股东户数为5.37万户,较10月31日增加1106.0户,增幅为2.1%。在中药行业个股中,东阿阿胶股东户数高于行业平均水平,截至11月8日,中药行业平均股东户数为5.04万户。从股价来看,2024年10月31日至2024年11月8日,东阿阿胶区间涨幅为2.43%,在此期间股东户数增加1106.0户,增幅为2.1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100026722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0028","BK0175","BK0239","BK0188","000423","BK0183","BK0010","BK0187","BK0196"],"gpt_icon":0},{"id":"2485846489","title":"老百姓大药房直营门店卷入东阿阿胶追溯码重复风波 今年前三季度盈利下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2485846489","media":"中金在线","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485846489?lang=zh_cn&edition=full","pubTime":"2024-11-21 10:52","pubTimestamp":1732157532,"startTime":"0","endTime":"0","summary":"业绩下滑之下, 老百姓 一家直营门店成为医保核查对象近期, 东阿阿胶 因药品追溯码重复备受关注。老百姓的全资子公司老百姓大药房连锁(陕西)有限公司直营门店西安王寺西街店出现在东阿阿胶药品追溯码核查名单中。为查明药品追溯码重复采集且发生医保基金结算的原因,国家医保局要求各相关医保部门、定点医药机构和医药机构开展自查及时配合开展自查工作。此次并非老百姓首次因违规使用医保基金被通报。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121105805a24a1e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121105805a24a1e02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","603883","BK0175","BK0183","BK0188","BK0209","BK0187","BK0196","BK0239","SG9999014674.SGD","BK0010","000423"],"gpt_icon":0},{"id":"2485472176","title":"东阿阿胶新提交3件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2485472176","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485472176?lang=zh_cn&edition=full","pubTime":"2024-11-21 05:37","pubTimestamp":1732138634,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日东阿阿胶股份有限公司新提交3件商标注册申请。商标申请详情如下:今年以来东阿阿胶股份有限公司新申请注册商标14件,截止目前公司共持有注册商标1517件,另有280件商标尚在注册申请中。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100003495.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000423","BK0183","BK0188","BK0196","BK0239","BK0175","BK0028","SG9999014674.SGD","BK0187","BK0010"],"gpt_icon":0},{"id":"2484097654","title":"东阿阿胶获得发明专利授权:“猪苓汤、猪苓浸膏、猪苓固体制剂的制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2484097654","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484097654?lang=zh_cn&edition=full","pubTime":"2024-11-20 02:11","pubTimestamp":1732039899,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示东阿阿胶新获得一项发明专利授权,专利名为“猪苓汤、猪苓浸膏、猪苓固体制剂的制备方法”,专利申请号为CN202211174012.7,授权日为2024年11月19日。本发明提供的猪苓汤的制备方法综合考量水提与浓缩:保证了得到的猪苓汤与传统猪苓汤剂基准样品提取效果的一致性,所得猪苓汤中有效活性成分含量高,药效好。今年以来东阿阿胶新获得专利授权9个,较去年同期减少了30.77%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000002642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000423","BK0175","BK0196","SG9999014674.SGD","BK0183","BK0010","BK0187","BK0028","BK0239","BK0188"],"gpt_icon":0},{"id":"2482792885","title":"东阿阿胶(000423)11月11日主力资金净卖出853.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482792885","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482792885?lang=zh_cn&edition=full","pubTime":"2024-11-12 09:22","pubTimestamp":1731374539,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月11日收盘,东阿阿胶报收于59.0元,下跌2.14%,换手率1.24%,成交量7.97万手,成交额4.69亿元。近5日资金流向一览见下表:东阿阿胶融资融券信息显示,融资方面,当日融资买入5468.55万元,融资偿还5903.09万元,融资净偿还434.54万元。东阿阿胶主营业务:主要从事阿胶和阿胶系列及其他中成药等产品的研发、生产和销售,是阿胶行业标准制定的引领者,是中式滋补健康引领者和中药企业高质量发展的典范。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200007862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000423","BK0187","BK0196","BK0239","BK0010","BK0028","BK0188","SG9999014674.SGD","BK0175","BK0183"],"gpt_icon":0},{"id":"2482153464","title":"新董事长上任12天,东阿阿胶就陷入“追溯码风波”","url":"https://stock-news.laohu8.com/highlight/detail?id=2482153464","media":"市场资讯","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482153464?lang=zh_cn&edition=full","pubTime":"2024-11-09 10:03","pubTimestamp":1731117780,"startTime":"0","endTime":"0","summary":"近日,刚刚发完2024年前三季度营收、净利双增的财报,东阿阿胶的明星产品复方阿胶浆就因被举报,陷入“追溯码”风波。据11月2日国家医保局公告,复方阿胶浆存在药品追溯码重复情况,且均发生医保基金结算,涉及11个省份的46家医药机构。 11月2日当天,东阿阿胶便发布关声明表示,公司生产的所有复方阿胶浆产品,均按照国家有关法律法规执行,严格执行一药一码。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-09/doc-incvmvxq2946151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0183","BK0028","BK0010","BK0188","SG9999014674.SGD","BK0175","BK0196","000423","BK0187","BK0239"],"gpt_icon":0},{"id":"2481906730","title":"东阿阿胶与九州通及国大药房签订战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2481906730","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481906730?lang=zh_cn&edition=full","pubTime":"2024-11-07 20:08","pubTimestamp":1730981280,"startTime":"0","endTime":"0","summary":"11月7日,第七届中国国际进口博览会上,东阿阿胶股份有限公司与九州通医药集团股份有限公司、国药控股国大药房有限公司分别签订了战略合作协议。东阿阿胶董事长程杰、副总裁刘广源,九州通医药集团副董事长、集团总经理龚翼华,国药控股股份有限公司董事会秘书、国药集团一致药业股份有限公司董事长吴壹建,国药控股国大药房有限公司总经理仲向军等出席了本次签约仪式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-07/doc-incvfyqu8942354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0146","BK0183","BK0028","BK0077","BK0010","BK0250","BK0188","SG9999014674.SGD","BK0175","BK0012","BK0097","BK0196","600998","BK0201","000423","BK0187","BK0239","BK0039"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1996-07-29","address":"山东省聊城市东阿县阿胶街78号","stockEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.2663},{"period":"6month","weight":-0.0742},{"period":"1year","weight":0.2823},{"period":"ytd","weight":0.2745}],"companyName":"东阿阿胶股份有限公司","boardCode":"AI0027","perCapita":"11960股","boardName":"医药制造业","registeredCapital":"64397万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":" 东阿阿胶股份有限公司主营业务为阿胶和阿胶系列及其他中成药等产品的研发、生产和销售。公司主要产品有阿胶、复方阿胶浆、阿胶糕、“真颜”品牌系列、阿胶粉。2023年东阿阿胶品牌强度和品牌价值得到了跳跃式提升,第14次入围世界品牌实验室发布的“中国500最具价值品牌”,荣获第十四届虎啸奖【联合营销类】金奖、“中国中药企业TOP100排行榜”、上榜中国最具品牌价值榜单(中华老字号),荣登健康产业品牌榜及健康产业品牌价值榜。6月19日,世界品牌实验室(World Brand Lab)发布了2024年《中国500最具价值品牌》分析报告,东阿阿胶第15次荣登《中国500最具价值品牌》榜单,以438.37亿元人民币的品牌价值位列榜单第249位。","serverTime":1734705852123,"listedPrice":5.28,"stockholders":"53842人(较上一季度增加0.33%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东阿阿胶(000423)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东阿阿胶(000423)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东阿阿胶,000423,东阿阿胶股票,东阿阿胶股票老虎,东阿阿胶股票老虎国际,东阿阿胶行情,东阿阿胶股票行情,东阿阿胶股价,东阿阿胶股市,东阿阿胶股票价格,东阿阿胶股票交易,东阿阿胶股票购买,东阿阿胶股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东阿阿胶(000423)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东阿阿胶(000423)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}